Skip to content

A clinical study on screening for biomarkers in high altitude-induced disorders of gut-brain and gut-lung axis

A study on the mechanisms of gut microbiota in high altitude-induced disorders of gut-brain and gut-lung axis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2200067073
Enrollment
Unknown
Registered
2022-12-26
Start date
2023-01-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

High altitude sickness

Interventions

Plain environment group:NA

Sponsors

Army Medical Center (Daping Hospital)
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1) Aged 18-45, without any known infectious diseases; Not been to endemic diarrhea areas in the last 6 months; Have lived in plain/plateau environment in the past 6 months. 2) In a healthy condition, normal weight, body mass index (BMI) 18.5-24.9 kg/m2; 3) No complications of heart, brain, lung, liver, kidney and other serious diseases, no mental disorders, with normal communication skills 4) With no alcoholism 5) No history of ulcerative colitis or other gastrointestinal diseases 6) Not taking any antacids, gastrointestinal motility drugs, antibiotics and live intestinal microflora preparations (such as yogurt) within the past 4 weeks 7) Signed the informed consent form and agreed to participate in the study.

Exclusion criteria

Exclusion criteria: 1) History of autoimmune disease and digestive system surgery; 2) Atopic diseases, such as eczema, asthma, and gastrointestinal eosinophil-related diseases; 3) Took antibiotics, drugs that cause intestinal microecological disorders, and any immunosuppressive agents within the past 3 months. 4) Pregnant and lactating women; 5) Complicated with hypertension, diabetes, heart disease, stroke or severe chronic diseases (infectious, hereditary, metabolic, endocrine diseases); 6) Subjects who are unable to cooperate with the study or who are considered by the investigator to be unsuitable for the study.

Design outcomes

Primary

MeasureTime frame
Change in gut microbiota;

Secondary

MeasureTime frame
Change in metabolic compounds;Gastrointestinal disorders;Depression and anxiety;Fatigue;Sleep condition;Health condition;

Countries

China

Contacts

Public ContactWei Yanling

Army Medical Center (Daping Hospital)

lingzi016@126.com15310354666

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026